“The revised rating reflects limited operating flexibility as management moves into and operationalizes its new patient tower in fiscal [year] 2017, and as SARH adds new costs to its operating base which may take a couple of years to stabilize given the size and scale of the project,” said S&P analyst Aamna Shah.
The outlook is stable.
More articles on healthcare finance:
For-profit hospital stock report: Week of Dec. 5-9
Zirmed named to Built In Chicago 2016 Top 100 Digital Companies list
Moody’s revises Vidant Health’s outlook to stable
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
